Cargando…
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
BACKGROUND: High orphan drug prices have gained the attention of payers and policy makers. These prices may reflect the need to recoup the cost of drug development from a small patient pool. However, estimates of the cost of orphan drug development are sparse. METHODS: Using publicly available data,...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327525/ https://www.ncbi.nlm.nih.gov/pubmed/30630499 http://dx.doi.org/10.1186/s13023-018-0990-4 |